Cyberattacks against accounting software firm Wolters Kluwer and the City of Baltimore in May showed how the newest wave of malicious hacking can have significant, often...Technologyread more
The European parliamentary election is the second largest democratic exercise in the world.Europe Newsread more
Buybacks have gotten a bad rap from both Republicans and Democrats. But stocks would be trading at a massive discount without them.Marketsread more
Biden had criticized Kim Jong Un as a "dictator" and a "tyrant" at a recent rally in Philadelphia. North Korean state media responded by calling Biden a "fool of low IQ" among...Politicsread more
Fiat Chrysler and France's Renault could soon partner up to take on the sweeping changes to the global auto industry, according to a report in the Financial Times. The...Autosread more
Microsoft shares have gained 133% since November 2015, outperforming a tech "basket of unicorns" over that stretch.Technologyread more
The president's state visit comes amid tensions with carmaker Toyota over potential auto tariffs. Trump has repeatedly threatened Japanese and European carmakers with tariffs.Traderead more
The IRS is about to release a new draft of Form W-4, which will more closely reflect the changes stemming from the Tax Cuts and Jobs Act. For workers, that means they'll need...Personal Financeread more
The Mega Millions jackpot has spilled over $400 million. It would be the ninth largest winning since the game began in 2002.Personal Financeread more
Trump was speaking at a meeting of Japanese business leaders in Tokyo during his state visit to Japan on Saturday.Marketsread more
The biggest U.S. gasoline price surge in years is running out of steam just in time for the start of the summer driving season.Energyread more
has built its business around tracking users' steps and heart rate.
But with the company's stock price down 62 percent in the past year and Apple threatening its market leadership, Fitbit's future might be predicated on its success in the medical sector.
Fitbit is building tools to help diagnose and monitor sleep apnea, a disorder that affects some 18 million American adults, the company told CNBC.
Sleep apnea is characterized by pauses in breathing and shallow breath and comes with an increased risk of heart failure, obesity and strokes. One of the biggest concerns is that a lot of people don't realize they have it.
"We'd perform a useful public service by alerting users to the fact that they have a problem," said Conor Heneghan, Fitbit's lead research scientist, in an interview. Heneghan works on Fitbit's research and development team, which is focused on testing out new biomedical sensors and exploring potential applications.
Sleep apnea is also a big potential market, with revenue expected to increase to $6.7 billion by 2021 from $4.6 billion last year, according to Research and Markets.
Fitbit, which makes products such as the Flex 2 fitness tracker and Blaze smartwatch, is looking for new ways to keep pace with chief rival in the competitive wearables market. Apple Watch overtook Fitbit in the first quarter of 2017, according to a report from the market research firm Strategy Analytics.
Fitbit's shipments sank 35 percent in the first quarter from the prior year to 2.9 million devices.
Helping diagnose and treat sleep apnea is a major target for tech companies, ranging from small start-ups to bigger companies like Fitbit, because it can be detected with existing sensors. Fitbit plans to track heart rate and fluctuations in oxygen levels.
More specifically, Heneghan's team is looking into using optical technologies that shine a light into the skin. Blood that is highly oxygenated is red, but gets bluer with less oxygen. The technology tracks dips in oxygen levels during the night, a possible indicator of sleep apnea.
"We're leveraging the fact that Fitbit has experience in optical electronics, and making them small and power efficient," said Heneghan.
Fitbit isn't the only wearables company exploring applications beyond health and fitness. Apple is working on an effort to non-invasively track blood glucose, CNBC reported in April. And Jawbone, maker of the UP bands, is now shifting from consumer trackers to clinical health products.
For millions of people with chronic illnesses, whether it's diabetes, heart disease or sleep apnea, these devices become dramatically more useful if they can collect and interpret medical information. The major challenge is getting clearance from the U.S. Food and Drug Administration, which requires both time and resources.
"Sleep apnea is a huge market and a target that has very clear definitions, relative to other diseases," said Roy Raymann, vice president of sleep science at SleepScore Labs, and the former sleep expert on Apple's health team.
Fitbit is currently working with sleep labs to study how prototypes perform in detecting sleep apnea. Heneghan expects to bring its sleep apnea product to market within a year, if the company can prove to the medical community that the device is sufficiently accurate.
The company isn't yet certain how much it will need to work with the FDA and regulators in other countries. The device will most likely nudge a user to see a doctor rather than making a diagnosis. It might also help monitor how treatments are working, so the user can make an informed decision about whether to continue or try an alternative.
"Doctors are often ultraconservative, so it remains to be seen whether they'll accept data from a consumer wearable," said Raymann.